Global University venturing has awarded the 2018 Deal of the Year Award to UCLB spinout, Orchard Therapeutics; a biotechnology company dedicated to transforming [...]
The UCL Technology Fund (UCLTF), UK Innovation & Science Seed Fund (UKI2S), alongside support from Innovate UK, have invested in UCL spinout company [...]
Hazy (formerly Anon AI), one of our spin out companies, has won this year’s Microsoft Innovate AI competition. The award highlights start-ups harnessing the pow [...]
Today, the clinical-stage gene therapy company, announced its recent strategic agreement with GSK, to acquire its portfolio of approved and investigational rare [...]
UCL spinout company, Intrinsic, launched its new website today. Intrinsic was established to commercialise the novel memristive RRAM devices developed by Prof T [...]
Wired’s Klint Finley discusses some of the benefits that sound-based technology can provide to today’s businesses. With wireless technology being so commonly us [...]
UCL spinout company, Puridify Limited, developers of bioprocessing technologies to significantly advance industrial biomolecule manufacture has been acquired by [...]
Proceeds will be used to establish clinical proof of concept for three novel haematological cancer programs UCL Business spinout company, Autolus Limited, a cli [...]
• The Company’s Antha operating system brings end-to-end digitization to biotechnology, replacing current artisanal methods of development • Speaking from the W [...]
AUTO3 is the first dual targeting CAR-T cell therapy to enter clinical studies targeting CD19 and CD22 with independently-acting CARs. UCL Business spinout comp [...]
